Work

192P Impact of oncogenic fibroblast growth factor receptor (FGFR) alterations in patients with advanced solid tumors in a real-world setting

Year: 2023

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.2916

Authors: H. Sweiti, L. Demirdjian, S. Triantos, K. Standish, S. Thomas, J. Greshock, Q. Xia, J. Paone, P. Sheridan, S. Pant, C. Massard, D.A. Reardon, Y. Loriot, M.H.H. Schuler

Institutions: Janssen Research & Development (United States), Aetion (United States), The University of Texas MD Anderson Cancer Center, Institut Gustave Roussy, Dana-Farber Cancer Institute

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Janssen Research and Development

OpenAlex ID: W4387810063

FWCI: 0.075

Cites:

Cited by: 1

Related to: 10